You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Flu (Influenza) Vaccine Market By Key Players (Pfizer, Emergent BioSolutions, CSL (Novartis), GlaxoSmithKline)

The report on the Global Flu (Influenza) Vaccine Market has published by the Market Research Store. The report provides the client the latest trending insights about the Flu (Influenza) Vaccine market. You will find in the report include market value and growth rate, size, production consumption and gross margin, pricings, and other influential factors. Along with these you will get detailed information about all the distributors, suppliers and retailers of the Flu (Influenza) Vaccine market in the report. The competitive scenario of all the industry players are mentioned in-detail in the report. Due to the pandemic the market players have strategically changed their business plans.
Some of the key industry players that are operating in the Flu (Influenza) Vaccine market are:
Pfizer
Merck & Co
Emergent BioSolutions
GlaxoSmithKline
CSL (Novartis)
Bavarian Nordic
Sanofi Pasteur
Inovio Pharmaceuticals
Mitsubishi Tanabe Pharma
Novavax
Through the month of the analysis, research analysts predicted that the Flu (Influenza) Vaccine market reached XX million dollars in 2019 and the market demand will reach XX million dollars by 2026. During the forecast period 2020 to 2026 the expected CAGR is XX%. The increasing investments in the research and development activities and the rising technological advancements in the Flu (Influenza) Vaccine market, increasing the market growth.
Due to the increase of pandemic world-wide several market issues has generated around the world. Such as, economic crisis in various regions along with loss of employment.
The questions that are answered in the report:
What are the challenges for the Flu (Influenza) Vaccine market created by the outbreak of the global pandemic?
What are the drivers that are shaping the Flu (Influenza) Vaccine market?
What are the top opportunities that are currently ruling the market?
What are the segments of the Flu (Influenza) Vaccine market that are given in the report?
What are the developing regions in the Flu (Influenza) Vaccine market?
Overall industries are struggling on the global platform to revive the markets. It has been observed that through the pandemic almost every market domain has been impacted.
Market Segmentation
The Flu (Influenza) Vaccine market regional presence is showcased in five major regions Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. In the report, the country-level analysis is also provided.
The Flu (Influenza) Vaccine market is segmented into Product Types:
Inactivated Influenza Vaccines (IIV)
Live Attenuated Influenza Vaccines (LAIV)
The Flu (Influenza) Vaccine market is segmented into By End User/Application:
For Children (6 months to 3 years)
For Adults and Children over 3 years
The major points that are covered in the report:
Overview: In this section, the global Flu (Influenza) Vaccine Market definition is given, with an overview of the report in order to provide a board outlook about the nature and contents of the research study.
Strategies Analysis of Industry Players: This Strategic Analysis will help to gain competitive advantage over their competitors to the market players.
Essential Market Trends: Depth analysis of the market’s latest and future trends is provided in this section.
Market Forecasts: In this segment, accurate and validated values of the total market size in terms of value and volume have provided by the research analyst. Also the report include production, consumption, sales, and other forecasts for the global Flu (Influenza) Vaccine Market.
Regional Analysis: In the global Flu (Influenza) Vaccine market report major five regions and its countries have been covered. Market players will have estimates about the untapped regional markets and other benefits with the help of this analysis.
Segment Analysis: Accurate and reliable foretell about the market share of the essential sections of the Flu (Influenza) Vaccine market is provided.
Regional Segmentation
North America
Latin America
Europe
Asia Pacific
Middle East and Africa
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Flu (Influenza) Vaccine Market Share by Type (2020-2026)
1.5.2 Inactivated Influenza Vaccines (IIV)
1.5.3 Live Attenuated Influenza Vaccines (LAIV)
1.6 Market by Application
1.6.1 Global Flu (Influenza) Vaccine Market Share by Application (2020-2026)
1.6.2 For Children (6 months to 3 years)
1.6.3 For Adults and Children over 3 years
1.7 Flu (Influenza) Vaccine Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Flu (Influenza) Vaccine Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Flu (Influenza) Vaccine Market
3.1 Value Chain Status
3.2 Flu (Influenza) Vaccine Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Flu (Influenza) Vaccine
3.2.3 Labor Cost of Flu (Influenza) Vaccine
3.2.3.1 Labor Cost of Flu (Influenza) Vaccine Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Pfizer
4.1.1 Pfizer Basic Information
4.1.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.1.3 Pfizer Flu (Influenza) Vaccine Market Performance (2015-2020)
4.1.4 Pfizer Business Overview
4.2 Merck & Co
4.2.1 Merck & Co Basic Information
4.2.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.2.3 Merck & Co Flu (Influenza) Vaccine Market Performance (2015-2020)
4.2.4 Merck & Co Business Overview
4.3 Emergent BioSolutions
4.3.1 Emergent BioSolutions Basic Information
4.3.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.3.3 Emergent BioSolutions Flu (Influenza) Vaccine Market Performance (2015-2020)
4.3.4 Emergent BioSolutions Business Overview
4.4 GlaxoSmithKline
4.4.1 GlaxoSmithKline Basic Information
4.4.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.4.3 GlaxoSmithKline Flu (Influenza) Vaccine Market Performance (2015-2020)
4.4.4 GlaxoSmithKline Business Overview
4.5 CSL (Novartis)
4.5.1 CSL (Novartis) Basic Information
4.5.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.5.3 CSL (Novartis) Flu (Influenza) Vaccine Market Performance (2015-2020)
4.5.4 CSL (Novartis) Business Overview
4.6 Bavarian Nordic
4.6.1 Bavarian Nordic Basic Information
4.6.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.6.3 Bavarian Nordic Flu (Influenza) Vaccine Market Performance (2015-2020)
4.6.4 Bavarian Nordic Business Overview
4.7 Sanofi Pasteur
4.7.1 Sanofi Pasteur Basic Information
4.7.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.7.3 Sanofi Pasteur Flu (Influenza) Vaccine Market Performance (2015-2020)
4.7.4 Sanofi Pasteur Business Overview
4.8 Inovio Pharmaceuticals
4.8.1 Inovio Pharmaceuticals Basic Information
4.8.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.8.3 Inovio Pharmaceuticals Flu (Influenza) Vaccine Market Performance (2015-2020)
4.8.4 Inovio Pharmaceuticals Business Overview
4.9 Mitsubishi Tanabe Pharma
4.9.1 Mitsubishi Tanabe Pharma Basic Information
4.9.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.9.3 Mitsubishi Tanabe Pharma Flu (Influenza) Vaccine Market Performance (2015-2020)
4.9.4 Mitsubishi Tanabe Pharma Business Overview
4.10 Novavax
4.10.1 Novavax Basic Information
4.10.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.10.3 Novavax Flu (Influenza) Vaccine Market Performance (2015-2020)
4.10.4 Novavax Business Overview

5 Global Flu (Influenza) Vaccine Market Analysis by Regions
5.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Regions
5.1.1 Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
5.1.2 Global Flu (Influenza) Vaccine Revenue by Regions (2015-2020)
5.2 North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.3 Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.6 South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

6 North America Flu (Influenza) Vaccine Market Analysis by Countries
6.1 North America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
6.1.1 North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
6.1.2 North America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
6.1.3 North America Flu (Influenza) Vaccine Market Under COVID-19
6.2 United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.2.1 United States Flu (Influenza) Vaccine Market Under COVID-19
6.3 Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.4 Mexico Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7 Europe Flu (Influenza) Vaccine Market Analysis by Countries
7.1 Europe Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)
7.1.2 Europe Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
7.1.3 Europe Flu (Influenza) Vaccine Market Under COVID-19
7.2 Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.2.1 Germany Flu (Influenza) Vaccine Market Under COVID-19
7.3 UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.3.1 UK Flu (Influenza) Vaccine Market Under COVID-19
7.4 France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.4.1 France Flu (Influenza) Vaccine Market Under COVID-19
7.5 Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.5.1 Italy Flu (Influenza) Vaccine Market Under COVID-19
7.6 Spain Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.6.1 Spain Flu (Influenza) Vaccine Market Under COVID-19
7.7 Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.7.1 Russia Flu (Influenza) Vaccine Market Under COVID-19

8 Asia-Pacific Flu (Influenza) Vaccine Market Analysis by Countries
8.1 Asia-Pacific Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Flu (Influenza) Vaccine Market Under COVID-19
8.2 China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.2.1 China Flu (Influenza) Vaccine Market Under COVID-19
8.3 Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.3.1 Japan Flu (Influenza) Vaccine Market Under COVID-19
8.4 South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.4.1 South Korea Flu (Influenza) Vaccine Market Under COVID-19
8.5 Australia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.6 India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.6.1 India Flu (Influenza) Vaccine Market Under COVID-19
8.7 Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Flu (Influenza) Vaccine Market Under COVID-19

9 Middle East and Africa Flu (Influenza) Vaccine Market Analysis by Countries
9.1 Middle East and Africa Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Flu (Influenza) Vaccine Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Flu (Influenza) Vaccine Market Under COVID-19
9.2 Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.3 UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.5 Nigeria Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.6 South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10 South America Flu (Influenza) Vaccine Market Analysis by Countries
10.1 South America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
10.1.1 South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
10.1.2 South America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
10.1.3 South America Flu (Influenza) Vaccine Market Under COVID-19
10.2 Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.2.1 Brazil Flu (Influenza) Vaccine Market Under COVID-19
10.3 Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.4 Columbia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.5 Chile Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

11 Global Flu (Influenza) Vaccine Market Segment by Types
11.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Types (2015-2020)
11.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Types (2015-2020)
11.2 Inactivated Influenza Vaccines (IIV) Sales and Price (2015-2020)
11.3 Live Attenuated Influenza Vaccines (LAIV) Sales and Price (2015-2020)

12 Global Flu (Influenza) Vaccine Market Segment by Applications
12.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Applications (2015-2020)
12.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Applications (2015-2020)
12.2 For Children (6 months to 3 years) Sales, Revenue and Growth Rate (2015-2020)
12.3 For Adults and Children over 3 years Sales, Revenue and Growth Rate (2015-2020)

13 Flu (Influenza) Vaccine Market Forecast by Regions (2020-2026)
13.1 Global Flu (Influenza) Vaccine Sales, Revenue and Growth Rate (2020-2026)
13.2 Flu (Influenza) Vaccine Market Forecast by Regions (2020-2026)
13.2.1 North America Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.2.2 Europe Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.2.3 Asia-Pacific Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.2.4 Middle East and Africa Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.2.5 South America Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.3 Flu (Influenza) Vaccine Market Forecast by Types (2020-2026)
13.4 Flu (Influenza) Vaccine Market Forecast by Applications (2020-2026)
13.5 Flu (Influenza) Vaccine Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140